NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

I generally agree with this though not with the point that it’s not relatively typical of a microcap development stage biotech without an approved product yet to warn that changing to a commercial company, including sales staff, and the lack thereof is a risk factor. Many of these companies are merged are bought, so yeah, not atypical, IMHO.

But your point that its removal suggests something significant has likely occurred of which we have not been made aware is a good insight.